...
首页> 外文期刊>Arthritis research & therapy. >Therapeutic benefit of balneotherapy and hydrotherapy in the management of fibromyalgia syndrome: A qualitative systematic review and meta-analysis of randomized controlled trials
【24h】

Therapeutic benefit of balneotherapy and hydrotherapy in the management of fibromyalgia syndrome: A qualitative systematic review and meta-analysis of randomized controlled trials

机译:理疗和水疗对纤维肌痛综合征治疗的治疗益处:随机对照试验的定性系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例

摘要

Introduction: In the present systematic review and meta-analysis, we assessed the effectiveness of different forms of balneotherapy (BT) and hydrotherapy (HT) in the management of fibromyalgia syndrome (FMS).Methods: A systematic literature search was conducted through April 2013 (Medline via Pubmed, Cochrane Central Register of Controlled Trials, EMBASE, and CAMBASE). Standardized mean differences (SMDs) and 95% confidence intervals (CIs) were calculated using a random-effects model.Results: Meta-analysis showed moderate-to-strong evidence for a small reduction in pain (SMD -0.42; 95% CI [-0.61, -0.24]; P 0.00001; I2 = 0%) with regard to HT (8 studies, 462 participants; 3 low-risk studies, 223 participants), and moderate-to-strong evidence for a small improvement in health-related quality of life (HRQOL; 7 studies, 398 participants; 3 low-risk studies, 223 participants) at the end of treatment (SMD -0.40; 95% CI [-0.62, -0.18]; P = 0.0004; I2 = 15%). No effect was seen at the end of treatment for depressive symptoms and tender point count (TPC).BT in mineral/thermal water (5 studies, 177 participants; 3 high-risk and 2 unclear risk studies) showed moderate evidence for a medium-to-large size reduction in pain and TPC at the end of treatment: SMD -0.84; 95% CI [-1.36, -0.31]; P = 0.002; I2 = 63% and SMD -0.83; 95% CI [-1.42, -0.24]; P = 0.006; I2 = 71%. After sensitivity analysis, and excluding one study, the effect size for pain decreased: SMD -0.58; 95% CI [-0.91, -0.26], P = 0.0004; I2 = 0. Moderate evidence is given for a medium improvement of HRQOL (SMD -0.78; 95% CI [-1.13, -0.43]; P 0.0001; I2 = 0%). A significant effect on depressive symptoms was not found. The improvements for pain could be maintained at follow-up with smaller effects.Conclusions: High-quality studies with larger sample sizes are needed to confirm the therapeutic benefit of BT and HT, with focus on long-term results and maintenance of the beneficial effects.
机译:前言:在目前的系统评价和荟萃分析中,我们评估了不同形式的balneotherapy(BT)和水疗(HT)在治疗纤维肌痛综合征(FMS)中的有效性。方法:进行系统性文献检索至2013年4月(Medline通过Pubmed,Cochrane对照试验中央寄存器,EMBASE和CAMBASE)。使用随机效应模型计算标准化平均差异(SMD)和95%置信区间(CIs)。结果:荟萃分析显示中度到强度的证据表明疼痛有小幅减轻(SMD -0.42; 95%CI [ -0.61,-0.24];关于HT(P = 0.00001; I2 = 0%)(8项研究,462名参与者; 3项低风险研究,223名参与者),以及中到强证据表明健康状况有所改善相关的生活质量(HRQOL; 7个研究,398名参与者; 3个低风险研究,223名参与者)(SMD -0.40; 95%CI [-0.62,-0.18]; P = 0.0004; I2 = 15%)。抑郁症状和压痛点计数(TPC)在治疗结束时未见效果。矿物质/热水中的BT(5个研究,177名参与者; 3个高风险和2个危险性不清楚的研究)显示了中等程度的证据,表明在治疗结束时将疼痛和TPC减至最大:SMD -0.84; 95%CI [-1.36,-0.31]; P = 0.002; I2 = 63%,SMD -0.83; 95%CI [-1.42,-0.24]; P = 0.006; I2 = 71%。经过敏感性分析并排除一项研究后,疼痛的影响范围减小了:SMD -0.58; 95%CI [-0.91,-0.26],P = 0.0004; I2 =0。为HRQOL的中等改善提供了中等证据(SMD -0.78; 95%CI [-1.13,-0.43]; P <0.0001; I2 = 0%)。没有发现对抑郁症状的显着影响。结论:需要进行更大样本量的高质量研究,以确认BT和HT的治疗益处,重点是长期结果和维持有益作用。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号